| Improvement of insulin sensitivity after lean donor feces in metabolic syndrome is driven by baseline intestinal microbiota composition RS Kootte, E Levin, J Salojärvi, LP Smits, AV Hartstra, SD Udayappan, ... Cell metabolism 26 (4), 611-619. e6, 2017 | 952 | 2017 |
| Bile acid receptors as targets for drug development FG Schaap, M Trauner, PLM Jansen Nature reviews Gastroenterology & hepatology 11 (1), 55-67, 2014 | 772 | 2014 |
| ApoAV reduces plasma triglycerides by inhibiting very low density lipoprotein-triglyceride (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis FG Schaap, PCN Rensen, PJ Voshol, C Vrins, HN van der Vliet, ... Journal of biological chemistry 279 (27), 27941-27947, 2004 | 402 | 2004 |
| The ascending pathophysiology of cholestatic liver disease PLM Jansen, A Ghallab, N Vartak, R Reif, FG Schaap, J Hampe, ... Hepatology 65 (2), 722-738, 2017 | 323 | 2017 |
| High expression of the bile salt‐homeostatic hormone fibroblast growth factor 19 in the liver of patients with extrahepatic cholestasis FG Schaap, NA van der Gaag, DJ Gouma, PLM Jansen Hepatology 49 (4), 1228-1235, 2009 | 323 | 2009 |
| Serum autotaxin is increased in pruritus of cholestasis, but not of other origin, and responds to therapeutic interventions AE Kremer, R van Dijk, P Leckie, FG Schaap, EMM Kuiper, T Mettang, ... Hepatology 56 (4), 1391-1400, 2012 | 301 | 2012 |
| Impaired long-chain fatty acid utilization by cardiac myocytes isolated from mice lacking the heart-type fatty acid binding protein gene FG Schaap, B Binas, H Danneberg, GJ van der Vusse, JFC Glatz Circulation research 85 (4), 329-337, 1999 | 256 | 1999 |
| Adenoviral overexpression of apolipoprotein AV reduces serum levels of triglycerides and cholesterol in mice HN van der Vliet, FG Schaap, JHM Levels, R Ottenhoff, N Looije, ... Biochemical and biophysical research communications 295 (5), 1156-1159, 2002 | 245 | 2002 |
| Sodium taurocholate cotransporting polypeptide (SLC10A1) deficiency: conjugated hypercholanemia without a clear clinical phenotype FM Vaz, CC Paulusma, H Huidekoper, M de Ru, C Lim, J Koster, ... Hepatology 61 (1), 260-267, 2015 | 235 | 2015 |
| Distinct fecal and oral microbiota composition in human type 1 diabetes, an observational study PF De Groot, C Belzer, Ö Aydin, E Levin, JH Levels, S Aalvink, F Boot, ... PloS one 12 (12), e0188475, 2017 | 205 | 2017 |
| Fibroblast growth factor 21 is induced by endoplasmic reticulum stress FG Schaap, AE Kremer, WH Lamers, PLM Jansen, IC Gaemers Biochimie 95 (4), 692-699, 2013 | 203 | 2013 |
| Bile acids drive the newborn’s gut microbiota maturation N van Best, U Rolle-Kampczyk, FG Schaap, M Basic, SWM Olde Damink, ... Nature communications 11 (1), 3692, 2020 | 172 | 2020 |
| The hepatic response to FGF19 is impaired in patients with nonalcoholic fatty liver disease and insulin resistance TCMA Schreuder, HA Marsman, M Lenicek, JR van Werven, ... American Journal of Physiology-Gastrointestinal and Liver Physiology 298 (3 …, 2010 | 169 | 2010 |
| Fatty acid-binding proteins in the heart FG Schaap, GJ van der Vusse, JFC Glatz Cardiac Metabolism in Health and Disease, 43-51, 1998 | 169 | 1998 |
| Evolution of the family of intracellular lipid binding proteins in vertebrates FG Schaap, GJ Van der Vusse, JFC Glatz Cellular lipid binding proteins, 69-77, 2002 | 167 | 2002 |
| The human gallbladder secretes fibroblast growth factor 19 into bile: towards defining the role of fibroblast growth factor 19 in the enterobiliary tract SJLB Zweers, KAC Booij, M Komuta, T Roskams, DJ Gouma, PLM Jansen, ... Hepatology 55 (2), 575-583, 2012 | 157 | 2012 |
| Cellular fatty acid transport in heart and skeletal muscle as facilitated by proteins J Luiken, FG Schaap, FA Van Nieuwenhoven, GJ Van der Vusse, ... Lipids 34, S169-S175, 1999 | 152 | 1999 |
| Alterations of hormonally active fibroblast growth factors after Roux-en-Y gastric bypass surgery PLM Jansen, J van Werven, E Aarts, F Berends, I Janssen, J Stoker, ... Digestive diseases 29 (1), 48-51, 2011 | 148 | 2011 |
| Liver resection for cancer: New developments in prediction, prevention and management of postresectional liver failure KMC van Mierlo, FG Schaap, CHC Dejong, SWMO Damink Journal of hepatology 65 (6), 1217-1231, 2016 | 141 | 2016 |
| Effect of ursodeoxycholic acid on bile acid profiles and intestinal detoxification machinery in primary biliary cirrhosis and health K Dilger, S Hohenester, U Winkler-Budenhofer, BAJ Bastiaansen, ... Journal of hepatology 57 (1), 133-140, 2012 | 140 | 2012 |
